Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001443459 | SCV001646430 | likely benign | Hypertrophic cardiomyopathy | 2024-05-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456744 | SCV002614994 | likely benign | Cardiovascular phenotype | 2020-06-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004808053 | SCV005430868 | likely benign | Cardiomyopathy | 2024-03-24 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001699789 | SCV001924992 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001702098 | SCV001929527 | likely benign | not provided | no assertion criteria provided | clinical testing |